Effectiveness of angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers on total and cardiovascular mortality and morbidity in primary prevention: A nationwide study based on French Health Insurance Data (SNDS)

Angiotensin‐converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) both inhibit the renin‐angiotensin system (RAS) but have different sites of action. Whether clinically meaningful differences exist is still debated. The authors set up a population‐based nationwide retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Oger, Emmanuel, Kerbrat, Sandrine, Nowak, Emmanuel, Paillard, François, Scarabin, Pierre‐Yves, Happe, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989753/
https://www.ncbi.nlm.nih.gov/pubmed/35229448
http://dx.doi.org/10.1111/jch.14445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989753/
https://www.ncbi.nlm.nih.gov/pubmed/35229448
http://dx.doi.org/10.1111/jch.14445

Ejemplares similares